Navigation Links
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
Date:9/5/2007

Pharmaceutical Industry Veteran Richard Franco and Entrepreneur Anthony

Ciabattoni Join NeoMatrix Board of Directors

IRVINE, Calif., Sept. 5 /PRNewswire/ -- NeoMatrix, developer of the HALO(TM) Breast Pap Test, the first automatic, noninvasive test designed to identify breast cancer risk, announced today that the company has closed a Series C round of equity financing. The financing will enable an expanded market release of the HALO System, which is designed to test asymptomatic women for the presence of atypical ductal hyperplasia (ADH), a known biomarker that can be a precursor to breast cancer. ADH is often found in the breast years earlier than a lesion might be found on a mammogram or a self exam, facilitating early follow-up and treatment or chemoprevention measures.

"We appreciate the continued support of our investors as we've surpassed more than 30 placements in Ob-Gyn and primary care offices around the country," said Paul J. Fitzpatrick, chief executive officer of NeoMatrix. "This fundraising has enabled us to hire our first sales representatives, expand our marketing team and to develop the infrastructure and marketing programs required to drive awareness and adoption of the HALO system. It also allowed us to convert or retire 100% of the debt previously used to finance the research and development of both the HALO system and its broad patent protection.

"In addition to our initial success in placing systems in physician offices, we have also recently established relationships with a number of breast specialists and breast centers who have agreed to help introduce HALO to their local primary-care referral networks. Although gynecologists and other primary care physicians are responsible for breast cancer screening of well, or asymptomatic women, breast specialists, often practicing in multi-specialty breast centers, assume responsibility for follow-up and treatment of high-risk patients," added Fitzpatrick.

'/>"/>
SOURCE NeoMatrix, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014 Continental Clinical Solutions, LLC ... clinical trials at its mid-Atlantic late-phase research facility, ... created with the idea of closing patient disparities ... in medical advances," said Continental's CEO, Saleh ... the immortal cell line of Henrietta Lacks, dubious ...
(Date:11/24/2014)... Senior Vice President, General Manager for Clinical ... acumen Elsevier , a world-leading provider ... congratulates Diane Bartoli , Senior Vice President and ... Solutions, for being recognized in the 13 th ... Profiles in Diversity Journal ® . ...
(Date:11/22/2014)... 2014 Prominent academics, leaders of ... on December 3rd at Genetic Rx, a networking ... will take place at the Joseph B. Martin ... discuss the present and future of genetic medicines—including ... gene editing—as well as the treatment of patients ...
(Date:11/22/2014)... November 22, 2014 The “Chiral ... Preparative), by Material (Metal, Glass, Plastic), by Application ... SFC] - Forecast to 2018” analyses and studies ... in North America, Europe, Asia, and Rest of ... and 15 figures spread through 135 pages and ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... which examines the science and applications of invisibility, Martin McCall ... type of invisibility cloak that does not just hide objects ... an example, McCall and Kinsler explain how a thief could, ... a safe, without even the CCTV surveillance cameras being aware. ...
... Corporation (Nasdaq: DNDN ) today announced ... use of PROVENGE® (sipuleucel-T), the first autologous cellular ... symptomatic metastatic castrate resistant (hormone refractory) prostate cancer ... Food and Drug Administration (FDA) approved the Los ...
... Calif., June 30, 2011 OXIS International, Inc. (OTC Bulletin ... that it has named David Saloff to its Board of ... independent Directors. "We are very pleased to have ... OXIS International Board of Directors," said Anthony J. Cataldo, Chairman ...
Cached Biology Technology:Why 'event cloaks' could be the key to the ultimate bank heist 2Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE 2Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE 3Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE 4OXIS International Names Healthcare Industry Entrepreneur David Saloff to Board of Directors 2OXIS International Names Healthcare Industry Entrepreneur David Saloff to Board of Directors 3
(Date:11/7/2014)... led by Dr. Debra Auguste, associate professor, biomedical ... The City College of New York, have identified ... for one of the most aggressive forms of ... have a high mortality rate owing to aggressive ... therapeutic options. However, Professor Auguste,s team, discovered the ...
(Date:11/6/2014)... for a predator. Except when that predator runs so fast ... to its size, is the fastest creature on Earth. Some ... second (at about five miles per hour). The fastest human ... gold from the tiger beetle, a person would have to ... has a problem. At peak speeds, everything becomes a blur. ...
(Date:11/4/2014)... LAKE CITY, Nov. 5, 2014 – University of Utah ... enzymes to help jet fuel produce electricity without needing ... be used to power portable electronics, off-grid power and ... online today in the American Chemical Society journal ... electricity through a chemical reaction between a fuel and ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2Jet-fueled electricity at room temperature 2
... nature or nurture determines an ant,s status in the ... Nature (that is, the ant,s genetic makeup) and nurture ... determining the fate of the Florida harvester ant, Pogonomyrmex ... the southeastern United States. The research team included ...
... in three U.S. public schools are in the "air ... University of Cincinnati (UC). UC researchers have ... schools are within 400 meters, or a quarter mile, ... and traffic routes. Research has shown that ...
... found in biology. Now, chemists have succeeded in making ... surface, much like miniature bedsprings in a frame. This ... can help researchers develop molecular electronics or solar cells, ... Physical chemists at the Department of Energy,s Pacific Northwest ...
Cached Biology News:Genes and nutrition influence caste in unusual species of harvester ant 2Genes and nutrition influence caste in unusual species of harvester ant 3Many US public schools in 'air pollution danger zone' 2Many US public schools in 'air pollution danger zone' 3Chemists make beds with soft landings 2Chemists make beds with soft landings 3
PMM2 Immunogen: PMM2 (NP_000294, 47 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
KRIT1 Immunogen: KRIT1 (NP_004903, 637 a.a. ~ 737 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Evolutionarily conserved signaling intermediate in Toll pathway...
Biology Products: